BDX vs OPY · P/E 34, rev $21.84B vs P/E 13, rev $1.43B
Becton Dickinson and Company (BDX) versus Oppenheimer Holdings Inc (OPY) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Oppenheimer Holdings Inc (OPY) is a capital markets company listed on NYSE.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported OPY revenue for 2024-12-31 was $1.43B. Net income was $71.2M. Revenue was up 14.7% from 2023-12-31 to 2024-12-31. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. OPY currently screens at market cap $1.15B and trailing P/E 12.8.
Not investment advice. Open the BDX and OPY stock pages for the full models.
Not investment advice.